Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR13F1 Inhibitors

OR13F1 inhibitors are a specialized class of chemical compounds designed to target the OR13F1 receptor, a member of the olfactory receptor family within the G-protein-coupled receptor (GPCR) superfamily. Olfactory receptors like OR13F1 are primarily recognized for their role in detecting odor molecules, which is fundamental to the sense of smell. However, the presence of OR13F1 in non-olfactory tissues suggests that this receptor may also have roles in various physiological processes beyond olfaction. Inhibitors of OR13F1 are designed to interact with the receptor in a manner that blocks or modulates its ability to bind with its natural ligands. This inhibition can lead to alterations in the receptor's signaling pathways, which may impact a range of biological functions. Understanding the action of OR13F1 inhibitors is essential for unraveling the broader biological significance of this receptor, particularly in tissues where its function is not fully understood. The chemical composition of OR13F1 inhibitors can vary, with different compounds exhibiting diverse mechanisms of action and specificity. Some OR13F1 inhibitors act as competitive antagonists, directly binding to the receptor's active site to prevent natural ligands from engaging and activating the receptor. This competitive mechanism effectively blocks the receptor's signaling capabilities. Other inhibitors may function allosterically, binding to different regions of the receptor and inducing conformational changes that either reduce its activity or alter its signaling behavior. The design and development of OR13F1 inhibitors typically involve detailed structural studies, including techniques such as X-ray crystallography, cryo-electron microscopy, and molecular modeling. These approaches are crucial for identifying critical binding sites on the receptor and optimizing the interactions between the inhibitors and OR13F1 to enhance their selectivity and potency. Researchers focus on creating inhibitors that are highly specific to OR13F1, minimizing off-target effects on other GPCRs or unrelated proteins. Through the study of OR13F1 inhibitors, scientists aim to gain deeper insights into the functional roles of this receptor in various biological systems and to explore how modulating its activity can influence different cellular processes.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

Non-selective beta-adrenergic antagonist that can modulate cAMP levels, potentially influencing OR13F1 signaling.

SQ 22536

17318-31-9sc-201572
sc-201572A
5 mg
25 mg
$93.00
$356.00
13
(1)

Adenylyl cyclase inhibitor that can reduce cAMP production, potentially affecting OR13F1 activity.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

Inhibits protein kinase A, which can disrupt cAMP-dependent pathways that may be involved in OR13F1 signaling.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

Inhibits MEK, which can affect ERK pathway signaling, potentially influencing OR13F1 activity.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$26.00
$92.00
$120.00
$310.00
$500.00
$908.00
$1821.00
46
(1)

Tyrosine kinase inhibitor that can disrupt phosphorylation events, possibly affecting OR13F1 signaling.

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$199.00
$460.00
$1479.00
1
(0)

P2X1 purinoceptor antagonist that can modulate extracellular ATP signaling, potentially affecting OR13F1.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$134.00
$502.00
7
(1)

Cdc42 inhibitor that can disrupt actin cytoskeleton remodeling, potentially affecting OR13F1 receptor trafficking.